Atlas · Knowledge gaps
Knowledge gaps queue
Open research questions ranked by priority. Each gap is a candidate for a debate or a SPEC-033 bounty challenge.
1,335
open gaps
| # | Title | Status | Priority | Domain | Created | |
|---|---|---|---|---|---|---|
| 1 | Where does TREM2 act in microglia? gap-a2dd9e142f0e | open | — | neurodegeneration | 2026-04-29 | Open → |
| 2 | Where does TREM2 act in microglia? gap-87890b7a924d | open | — | neurodegeneration | 2026-04-29 | Open → |
| 3 | Test Test gap-test-20260425-224949 | open | 0.900 | neurodegeneration | 2026-04-25 | Open → |
| 4 | What is the diagnostic specificity and sensitivity of motor band sign on 18F-FD… The authors explicitly state that heterogeneity of MNDs and variability across studies necessitate further research to establish specificity and sensitivity. Wi… gap-pubmed-20260410-192446-e28cf8c6 | open | 0.870 | neurodegeneration | 2026-04-10 | Open → |
| 5 | How do specific microbial metabolites affect CNS cell function during neuroinfl… The authors acknowledge that 'numerous mechanisms behind the impact of gut microbiota in neuro-development and pathogenesis remain poorly understood,' specifica… gap-pubmed-20260410-183201-e5534f58 | open | 0.860 | neurodegeneration | 2026-04-10 | Open → |
| 6 | How can glymphatic imaging biomarkers be validated for diagnostic use in neurod… The abstract identifies the 'potential' for diagnostic imaging biomarkers but doesn't address validation challenges or clinical implementation. This represents … gap-pubmed-20260411-070434-a4efc962 | open | 0.860 | neurodegeneration | 2026-04-11 | Open → |
| 7 | Should tau-targeted therapies be redesigned to account for Aβ-tau synergy rathe… The abstract suggests that trials directed solely at tau may need reconsideration given the synergistic relationship with Aβ. This raises fundamental questions … gap-pubmed-20260410-180503-26b108e7 | open | 0.860 | neurodegeneration | 2026-04-10 | Open → |
| 8 | How do roscovitine and tamoxifen's different mechanisms both effectively reduce… The abstract states these drugs have different mechanisms of action but both target Cdk5, yet provides no mechanistic explanation. Understanding these distinct … gap-pubmed-20260410-185251-a2373bc1 | open | 0.860 | neurodegeneration | 2026-04-10 | Open → |
| 9 | How does Gal3 regulate extracellular vesicle biogenesis in response to pTau sti… The study reveals that pTau enhances EV release in a Gal3-dependent manner, suggesting Gal3 controls EV biogenesis, but the underlying cellular machinery and si… gap-pubmed-20260411-080155-c867ed08 | open | 0.860 | neurodegeneration | 2026-04-11 | Open → |
| 10 | How do UCH-mediated ubiquitination imbalances differentially drive cancer versu… While both diseases show ubiquitination/deubiquitination imbalances involving UCHs, the specific mechanisms determining whether cells become malignant or degene… gap-pubmed-20260410-184203-136029e2 | open | 0.860 | neurodegeneration | 2026-04-10 | Open → |
| 11 | Is enhanced cholesterol synthesis in APOE4 carriers compensatory or directly pa… The debate highlighted conflicting interpretations of elevated cholesterol synthesis in APOE4 brains - protective compensation versus harmful dysregulation. Res… gap-debate-20260417-033108-dd0969dd | open | 0.850 | neurodegeneration | 2026-04-17 | Open → |
| 12 | What are the specific molecular mechanisms underlying the synergistic interacti… The abstract establishes that Aβ and tau have synergistic effects rather than acting independently, but the precise molecular mechanisms driving this interactio… gap-pubmed-20260410-180503-d1fe22bb | open | 0.850 | neurodegeneration | 2026-04-10 | Open → |
| 13 | Does SV2A hypoglycosylation cause or result from hippocampal hyperexcitability… The debate identified elevated CSF SV2A in AD but could not resolve whether glycosylation defects drive hyperexcitability or are downstream consequences. This c… gap-debate-20260417-033201-ac6f8caf | open | 0.850 | neurodegeneration | 2026-04-17 | Open → |
| 14 | How do SARS-CoV-2 proteins mechanistically accelerate pathological fibril forma… The abstract states that viral proteins can accelerate pathological fibril formation, but the specific molecular mechanisms are not explained. Understanding the… gap-pubmed-20260410-192024-66db1afc | open | 0.850 | neurodegeneration | 2026-04-10 | Open → |
| 15 | What specific molecular mechanisms drive AGE-mediated transformation of soluble… The abstract identifies AGEs as major crosslinkers causing neurofilament transformation to Lewy bodies but doesn't explain the specific biochemical processes in… gap-pubmed-20260411-091139-96d6831f | open | 0.850 | neurodegeneration | 2026-04-11 | Open → |
| 16 | What mechanisms explain sustained HD reversal persisting beyond huntingtin knoc… The abstract reports that disease reversal continues longer than the actual huntingtin reduction, suggesting unknown downstream mechanisms maintain therapeutic … gap-pubmed-20260410-180451-96600bbd | open | 0.850 | neurodegeneration | 2026-04-10 | Open → |
| 17 | What are the specific molecular mechanisms by which disease proteins disrupt Ca… The abstract states that amyloid beta-peptide, alpha-synuclein, and huntingtin adversely affect Ca2+ homeostasis by mechanisms that have been 'elucidated recent… gap-pubmed-20260410-180516-8cbcc91c | open | 0.850 | neurodegeneration | 2026-04-10 | Open → |
| 18 | What molecular mechanisms determine whether tau is routed to lysosomal degradat… The abstract describes a critical decision point where tau can either be degraded via lysosomes or secreted via exosomes, but the molecular switches governing t… gap-pubmed-20260410-145503-a204f61a | open | 0.850 | neurodegeneration | 2026-04-10 | Open → |
| 19 | How do protective variants in APOE and RELN mechanistically confer cognitive re… The abstract identifies rare protective variants in APOE and RELN genes but doesn't explain the specific molecular mechanisms by which these variants delay cogn… gap-pubmed-20260410-105533-c9e21630 | open | 0.850 | neurodegeneration | 2026-04-10 | Open → |
| 20 | What molecular mechanisms drive the transition from reversible LLPS droplets to… The abstract shows that fibrillization is enhanced in protein-rich droplets but doesn't explain the mechanistic transition from liquid to solid pathological agg… gap-pubmed-20260411-092125-f5372414 | open | 0.850 | neurodegeneration | 2026-04-11 | Open → |
| 21 | Which specific subtypes of early-life MDD confer independent high risk for late… The authors state that particular MDD subtypes may pose independent high AD risks but acknowledge their identification is problematical. This gap prevents targe… gap-pubmed-20260410-111158-9cd3873f | open | 0.850 | neurodegeneration | 2026-04-10 | Open → |
| 22 | What specific mechanisms underlie apoE4's acceleration of amyloid plaque format… The abstract states that apoE4 drives earlier and more abundant amyloids, but the precise molecular mechanisms explaining this isoform-specific difference in am… gap-pubmed-20260410-145430-9932fb3e | open | 0.850 | neurodegeneration | 2026-04-10 | Open → |
| 23 | How does aberrant IGF signaling mechanistically contribute to AD development an… The abstract identifies abnormalities in IGF signaling in AD patients and models but explicitly states the underlying molecular mechanisms remain unclear. Under… gap-pubmed-20260410-111218-bc72b8d2 | open | 0.850 | neurodegeneration | 2026-04-10 | Open → |
| 24 | What is the mechanism by which CD11c+ cells transport alpha-synuclein from brai… The abstract shows that ileal alpha-synuclein aggregates are contained within CD11c+ cells, but the cellular and molecular mechanisms of this brain-to-gut traff… gap-pubmed-20260411-073259-89538ba3 | open | 0.850 | neurodegeneration | 2026-04-11 | Open → |
| 25 | How does the reversibility of tau acetylation reconcile with stable prion-like… The debate highlighted that acetyltransferases and deacetylases dynamically regulate K280 acetylation within hours, yet prion models require stable templating. … gap-debate-20260412-094557-4878b574 | open | 0.850 | neurodegeneration | 2026-04-12 | Open → |
| 26 | What are the specific molecular mechanisms by which gut microbiota signals trav… The abstract proposes that Parkinson's disease originates in the gut and spreads to the CNS through the vagus nerve, but the precise molecular pathways mediatin… gap-pubmed-20260410-191933-4621dc31 | open | 0.850 | neurodegeneration | 2026-04-10 | Open → |
| 27 | What are the specific molecular mechanisms connecting Aβ toxicity and tau patho… The abstract mentions recent progress bringing Aβ and tau research together in a new paradigm but doesn't explain the mechanistic details of how membrane traffi… gap-pubmed-20260410-174535-59e4d072 | open | 0.850 | neurodegeneration | 2026-04-10 | Open → |
| 28 | Why do >95% of AD cases fail to clear Aβ peptides while <5% develop disease fro… The abstract identifies fundamentally different mechanisms between sporadic (clearance failure) and familial (overproduction) AD, but doesn't explain why cleara… gap-pubmed-20260410-171942-1d6ff714 | open | 0.850 | neurodegeneration | 2026-04-10 | Open → |
| 29 | How does RGS6 deficiency mechanistically lead to α-synuclein accumulation in do… The study shows RGS6-/- mice develop α-synuclein accumulation and identifies reduced cAMP signaling, but the molecular pathway connecting RGS6 loss to α-synucle… gap-pubmed-20260410-145520-2294b557 | open | 0.850 | neurodegeneration | 2026-04-10 | Open → |
| 30 | What are the specific molecular mechanisms underlying drug-resistant temporal l… The abstract explicitly states that mechanisms underlying TLE-HS are not fully understood, yet this represents the most common drug-resistant epilepsy in adults… gap-pubmed-20260410-191853-34bc98ec | open | 0.850 | neurodegeneration | 2026-04-10 | Open → |
| 31 | How does tauopathy develop in young brains with ADNP mutations versus age-relat… This study reveals extensive tauopathy in a 7-year-old brain with ADNP mutation, contradicting the established view that tauopathy primarily occurs in aging bra… gap-pubmed-20260410-170619-4a5e840e | open | 0.850 | neurodegeneration | 2026-04-10 | Open → |
| 32 | Is C1q elevation in human AD causally pathogenic or an epiphenomenon of neuroin… The domain expert noted lack of human genetic validation for C1q variants in AD GWAS, questioning whether C1q is a disease driver or consequence. This fundament… gap-debate-20260417-033237-9d1944ca | open | 0.850 | neurodegeneration | 2026-04-17 | Open → |
| 33 | Do the 432 differentially expressed proteins represent cause or consequence of… The study identifies extensive proteomic changes but cannot distinguish primary pathogenic drivers from secondary responses to neurodegeneration. This fundament… gap-pubmed-20260411-070323-b5e63788 | open | 0.850 | neurodegeneration | 2026-04-11 | Open → |
| 34 | How does RELN-COLBOS signaling mechanistically confer resilience despite extrem… The abstract shows RELN-COLBOS reduces tau phosphorylation and provides cognitive protection, but the specific molecular pathways linking RELN signaling to deme… gap-pubmed-20260411-090729-5d778902 | open | 0.850 | neurodegeneration | 2026-04-11 | Open → |
| 35 | What are the pathophysiological consequences of endosomal/lysosomal changes in… The abstract explicitly states that while endosomal/lysosomal alterations are among the earliest pathological changes in sporadic AD, their pathophysiological c… gap-pubmed-20260410-165354-62b37974 | open | 0.850 | neurodegeneration | 2026-04-10 | Open → |
| 36 | What is the temporal sequence of cholinergic loss versus stellate neuron death… The debate identified cholinergic dysfunction as the leading hypothesis but acknowledged causality remains unproven. Determining whether cholinergic loss preced… gap-debate-20260410-095546-54d22830 | open | 0.850 | neurodegeneration | 2026-04-10 | Open → |
| 37 | What upstream mechanisms trigger c-Jun upregulation specifically in Alzheimer's… The study identifies c-Jun upregulation as the key driver of TE mobilization and downstream pathology, but doesn't explain what causes this initial c-Jun elevat… gap-pubmed-20260411-071417-de019b1d | open | 0.850 | neurodegeneration | 2026-04-11 | Open → |
| 38 | How does impaired retromer function mechanistically lead to α-synuclein aggrega… The study demonstrates that Vps35 R524W expression causes α-synuclein aggregates but doesn't reveal the causal pathway linking endosomal dysfunction to protein … gap-pubmed-20260411-073254-dce6d16d | open | 0.850 | neurodegeneration | 2026-04-11 | Open → |
| 39 | What molecular mechanisms enable HMW tau to propagate more rapidly than fibrill… The study shows HMW tau promotes faster propagation to distal brain regions compared to fibrillar tau, despite similar seeding potency. The underlying mechanism… gap-pubmed-20260411-091147-d742b3b3 | open | 0.850 | neurodegeneration | 2026-04-11 | Open → |
| 40 | How does PEL24-199's non-competitive BACE1 modulation mechanistically reduce bo… The compound shows efficacy against both amyloid and tau pathologies through BACE1 modulation, but the molecular mechanism linking BACE1 activity to tau aggrega… gap-pubmed-20260411-091232-28e68dae | open | 0.850 | neurodegeneration | 2026-04-11 | Open → |
| 41 | Why do PARKIN-deficient mouse models fail to recapitulate human Parkinson's dis… Despite PARKIN mutations causing early-onset PD in humans, multiple mouse models show no motor impairment or neurodegeneration. This species difference undermin… gap-pubmed-20260410-171014-22b163bf | open | 0.850 | neurodegeneration | 2026-04-10 | Open → |
| 42 | How do CHCHD10 mutations cause mitochondrial dysfunction leading to FTD-ALS pat… While CHCHD10 is implicated in mitochondrial genome stability and cristae junction maintenance, the exact pathogenic mechanisms by which mutations in this gene … gap-pubmed-20260411-093917-8e1dc1cf | open | 0.850 | neurodegeneration | 2026-04-11 | Open → |
| 43 | Can O-GlcNAcase inhibitors achieve therapeutic selectivity for pathological tau… While O-GlcNAcylation was identified as the top translational target, the debate didn't address whether systemic O-GlcNAcase inhibition can selectively restore … gap-debate-20260412-094615-9a3f030c | open | 0.850 | neurodegeneration | 2026-04-12 | Open → |
| 44 | What are the specific mechanisms by which disrupted mitochondrial calcium cycli… The abstract states that disruption of mCa2+ cycling is implicated in neurodegeneration but doesn't explain the mechanistic pathways linking calcium dysregulati… gap-pubmed-20260410-110835-a0a0d0ad | open | 0.850 | neurodegeneration | 2026-04-10 | Open → |
| 45 | Which of the three proposed C9orf72 mechanisms (haploinsufficiency, RNA toxicit… The abstract presents three competing molecular mechanisms but states the exact mechanisms have not been elucidated. Determining the primary pathogenic mechanis… gap-pubmed-20260410-165504-09560a3d | open | 0.850 | neurodegeneration | 2026-04-10 | Open → |
| 46 | What mechanisms cause plasma p-tau231 and p-tau217 to increase before overt amy… The study shows these tau phosphorylation markers rise with the lowest Aβ burden, before detectable plaque pathology. The biological mechanism linking early amy… gap-pubmed-20260410-150552-1fc8e35e | open | 0.850 | neurodegeneration | 2026-04-10 | Open → |
| 47 | How does LRRK2's antimicrobial function relate to its role in Parkinson's disea… The abstract reveals LRRK2's central role in host defense against intracellular pathogens, but doesn't explain how this antimicrobial function connects to its e… gap-pubmed-20260410-213812-e52c5b34 | open | 0.850 | neurodegeneration | 2026-04-10 | Open → |
| 48 | What molecular mechanisms underlie the inverse association between cancer and n… The abstract identifies an inverse relationship between cancer and neurodegenerative diseases but doesn't explain the mechanistic basis. Understanding this para… gap-pubmed-20260410-184203-e7b8a0e1 | open | 0.850 | neurodegeneration | 2026-04-10 | Open → |
| 49 | How does ESCRT-mediated phagophore sealing mechanistically differ between PARKI… While the study shows ESCRT depletion inhibits both PARKIN-dependent and -independent mitophagy, the mechanistic basis for this universal requirement is unclear… gap-pubmed-20260410-174554-67bbf381 | open | 0.850 | neurodegeneration | 2026-04-10 | Open → |
| 50 | What molecular mechanisms drive the unique perivascular p-tau accumulation patt… While computational models predict the sulcal location based on mechanical deformation, the specific molecular pathways that translate mechanical stress into th… gap-pubmed-20260410-193732-e0df85d0 | open | 0.850 | neurodegeneration | 2026-04-10 | Open → |